Hubungan Kadar Magnesium Serum Dan Hba1c dengan Severitas Neuropati Diabetik

Andi Fadilah Yusran, Yuliarni Syafrita, Hendra Permana

Abstract

Low magnesium levels are known to be associated with increased risk of diabetes mellitus and its complications. In addition, HbA1c levels are also known to have a correlation with further diabetes complications such as diabetic neuropathy. Diabetic neuropathy is the most common microvascular complication in diabetes mellitus, whose incidence is associated with disability and mortality rates in diabetic patients. This study aimed to assess the correlation between serum magnesium levels and HbA1c with the severity of diabetic neuropathy. This was a cross-sectional study. Severity of diabetic neuropathy is classified according to the Baba's Diabetic Neuropathy Classification (BDC). All subjects were examined for serum magnesium and HbA1C levels. This study consisted of 46 diabetes mellitus subjects, with 69.6% of the subjects suffering from diabetic neuropathy. The average magnesium level in this study was 1.87 mg/dl ± 0.245 and the median HbA1c level was 8.6 %. There was no significant correlation between serum magnesium levels and HbA1c with the incidence and severity of diabetic neuropathy (p>0.05). However, there was a significant negative correlation between magnesium levels and HbA1c levels in diabetic neuropathy patients.

Keywords

Diabetes melitus, indeks massa tubuh, kadar HbA1c

Full Text:

PDF

References

Swaminathan R.Magnesium metabolism and its disorder. Clin Biochem Rev,2003: 24:47-66

Barbagallo M, Dominguez LJ. Magnesium metabolism in type 2 diabetesmellitus, metabolic syndrome and insulin resistance. Archives of Biochemistry and Biophysics, 2007; 458: 40-47

Dasgupta A, Sarma D, Saikia UK. Hypomagnesemia in type 2 diabetes mellitus. Indian Journal of Endorinology and Metabolism, 2012;16

Kirkland AE, Sarlo GL, Holton KF. The role of magnesium in neurological disorders. Nutrients, 2018;10: 730

Buxo JAD, Bonadio TLC. Choice of insulin administration route in diabetic peritoneal dialysis patients in Handbook of Dialysis Therapy, 4 ed. Elsevier, 2008; 1076-1085

Yosef T, Nureye D, Tekalign E. Poor glycemic control and its contributing factors among type 2 diabetes patients at Adama Hospital Mediacal College innEast Ethiopia. Diabetes Metab Syndr Obes. 2021, 14; 3273-3280

Su J, Zhao L, Zhang X, Cai H, Huang H, Xu F, et al. HbA1c variability anddiabetic peipheral neuropathy in type 2 diabetic patients. Cardiovasc Diabetol, 2018;17: 47

Ardeleanu V, Toma A, Pafili K, Papanas N, Motodei I, Diaconu CC, et al. Current pharmacological treatment of painful diabetic neuropathy: a narrative review.Medicina (Kaunas). 2020,56(1);25

Hurley RW, Henriquex OH, Wu CL. Neuropathic pain syndrome in Practical management of pain, fifth ed. Ed: Benzon HT, Rathmell JP, Wu CL, Turk DC, Argoff CE, Hurley RW. Philadelphia: Elsevier;.2014; 354-357

Chu C, Zhao W, Zhang Y, Li L, Lu J, Jiang L, et al. Low serum magnesium levels are associated with impaired peripheral nerve function in type 2 diabetic patients. Scientific reports,2016;6

Perkeni. Pedoman pengelolaan dan pencegahan diabetes melitus tipe 2 dewasa Indonesia. PB Perkeni 2019

Baba M, Suzuki C, Ogawa Y. Severity grading of diabetic neuropathy in type-2 diabetes by nerve conduction study: five-year prospective study in occurrence of diabetic foot, macroangiopathic events, and eventual death. Japanese journal of clinical neurophysiology, 2018;46(2): 71-77

Zhang Q, Ji L, Zheng H, Li Q, Xiong Q, Sun W, et al. Low serum phosphate and magnesium levels are associated with peripheral neuropathy in patients with type 2 diabetes mellitus. Diabetes Research and Clinical Practice, 2018; 146: 1-7

Gommers LM, Hoenderop JG, Bindels RJ, de Baaij JH. Hypomagnesemiain type 2 diaetes: a vicious circle?. Diabetes, 2016; 65: 3-12

Hyassat D, Sitri E, Batieha A, Elkhateeb M, Ajlouni K. Prevalence of hypomagnesemia among oese type 2 diabetic patients attending the National Center for Diabetes, Endocrinology and Genetics. International journal of endicronology and metabolisme. 2014; 12(3): e17796

Xu J, Xu W, Yao H, Sun W, Zhou Q, Cai L. Associations of serum and urinary magnesium with the pre-diabetes, diabetes and diabetic complications in the chinese northeast population. PLoS ONE,2013;8(2): e56750

Fasil A, Biadgo B, Abebe M. Glycemic control and diabetes complications among diabetes mellitus patients attending at University of Gondar Hospital, Northwest Ethiopia. Diabetic, Metabolic syndrome and obesity: targets and therapy, 2019;1275-83

Huang CC, Chen TW, Weng MC, Lee CL. Effect of glycemic control on electrophysiologic changes of diabetic neuropathy in type 2 diabetic patient. Kaohsiung J Med 2005;21: 15-21

Arpaci D, Tocoglu AG, Ergenc H, Korkmaz S, Ucar A, Tamer A, et al. Associations of serum magnesium levels with diabetes mellitus and diabetic complications. Hippokratia 2015; 19(2): 153-157

Zhang H, Ni J, Yu C, Wu Y, Li J, Liu J, et al. Sex-based differences in diabetes prevalance and risk factors: A population-based cross-sectional study among low-income adults in china. Front Endocrinol 2019; 10: 658

Murthy PS, Palvai K.. A study of serum magnesium levels in type 2 diabetes mellitus. International Journal of Scientific Study,2019; 6(10): 92-98

Khanna D, Bhatnagar M, Tayal S. Study of magnesium levels in type 2 diabetes mellitus. J Evolution Med Dent Sci,2020; 9(4): 206-210

Jamali AA, Jamali GM, Tanwani BM, Jamali AA, Tanwani Y, Jamali NM. Association of Hypomagnesemia in Type 2 Diabetic Patients with and without Peripheral Neuropathy. Journal of Diabetes Mellitus, 2018; 8: 27-42

Kurstjens S, Baaij JHF, Bouras H, Bindels RJM, Tack CJJ, Hoenderop JGJ. . Determinants of hypomagnesemia in patients with type 2 diabetes mellitus. European Journal of Endocrinology, 2017;176: 11-19

Li Z, Lei X, Xu B, Wang S, Gao T, Lv H. Analysis of risk factor of diabetes peripheral neuropathy in type 2 diabetes mellitus and nursing intervention.Exp Ther Med 2020;20(6): 127

Syed IA. Glycated hemoglobin: past, present, and futre are we ready for the change. J Pak Med Assoc 2011;61(4): 383-388

Gill HK, Yadav SB, Ramesh V, Bhatia E. A prospective study of prevalence and association of peripheral neuropathy in Indian patients with newly diagnosed type 2 diabetes mellitus. J Postgrad Med,2014; 60: 270 275

Mudjanarko SW & Nasution HN. Association of serum magnesium levelswith glycemic control in patients with type 2 diabetes mellitus. International Journal of Current Research, 2020; 12(1): 9531-9533

DOI: https://doi.org/10.26891/JIK.v16i1.2022.22-29

Refbacks

  • There are currently no refbacks.